After Biotech Dives Deeper Into Melanoma Data, It 'Continues to Impress'
Source: Streetwise Reports  (8/27/19)
Details from this clinical program are discussed, along with Q2/19 earnings and the next stock catalyst, in an H.C. Wainwright & Co. report. More >

'Topline Beat, All Eyes on Potential M&A' by Health Technologies Firm
Source: Streetwise Reports  (8/27/19)
An update on the Canadian company, including its Q2/19 results and its next expected catalyst, is provided in a Haywood report. More >

Developer of Premix for Livestock Feed Lands Sizable Order from Asia
Source: Streetwise Reports  (8/26/19)
Demand for the Canadian company's product is growing in the Asia-Pacific region. More >

Why Provention Bio Is in My Portfolio
Source: Daniel Carlson for Streetwise Reports  (8/23/19)
Orphan drug and breakthrough therapy status, which could mean this company's lead candidate is on the FDA fast track, translates to huge opportunities for both those suffering from diabetes and investors, says Daniel Carlson of Tailwinds Research. More >

Retrophin Shares Fall 30% on Failed Phase 3 FORT Study
Source: Streetwise Reports  (8/22/19)
Shares of Retrophin fell to a 52-week low on the news that topline results from its fosmetpantotenate Phase 3 FORT Study for PKNA treatment failed to meet expectations. More >

Small-Cap Logistics Company Partners with Aphria to Deliver Medical Cannabis
Source: Streetwise Reports  (8/22/19)
The initiative, to start in Calgary, is expected to expand rapidly into other cities. More >

Life Sciences Firm's OxC-beta Approved for Livestock Feed in Mexico
Source: Streetwise Reports  (8/21/19)
The country represents a significant market for feed consumption. More >

'Data Readouts Approaching in Two Pivotal Trials' for Biopharma Targeting Unmet Needs
Source: Streetwise Reports  (8/20/19)
The next steps for each of the programs are outlined in a Dawson James Securities report. More >

Medtronic Stock Hits All-Time High After Raising 2020 EPS Outlook
Source: Streetwise Reports  (8/20/19)
Dublin-based Medtronic reported Q1/20 earnings and revised its full-year earnings outlook upward sending shares up more than 5% today. More >

A Potential CBD Processor with 'Blue-Sky Prospects'
Source: Peter Epstein for Streetwise Reports  (8/20/19)
Peter Epstein of Epstein Research speaks with Martin Doane, CEO of Leviathan Cannabis Group, about the company's international plans to grow hemp and produce a hemp-derived CBD isolate and what sets the company apart from its peers. More >

Analyst Upgrade Ignites Duchenne's Muscular Dystrophy Research Firm's Shares
Source: Streetwise Reports  (8/16/19)
Solid Biosciences' shares are up by more than 40% today after Chardan Capital Markets upgraded the firm's shares from "neutral" to "buy" and raised its price target from $7.50 to $10.00/share. More >

InMode Reports Solid Q2 Earnings and Appoints Paula Abdul as Brand Ambassador
Source: Streetwise Reports  (8/14/19)
InMode Ltd. reported Q2/19 earnings and announced that international pop superstar Paula Abdul will be its brand ambassador sending shares "Straight Up" 15% as investors "Rush Rush" to purchase shares today. More >

Deciphera's Shares Open 115% Higher on Phase 3 Ripretinib Results
Source: Streetwise Reports  (8/13/19)
Deciphera Pharmaceuticals announced positive top-line results from the INVICTUS pivotal phase 3 clinical study of ripretinib in patients with advanced gastrointestinal stromal tumors. More >

Biotech's DMD Therapeutic 'Solidifies the Ground for Potential Pivotal Design'
Source: Streetwise Reports  (8/12/19)
The latest development concerning this clinical asset and other Q2/19 highlights are provided in an H.C. Wainwright & Co. report. More >

Amgen Shares React Favorably to Enbrel Patent Case Victory
Source: Streetwise Reports  (8/12/19)
Amgen shares are trading 5–6% higher today on news that the company has won its Enbrel (etanercept) patent court case. More >

Puma Biotech Shares Up More Than 20% on Q2 Earnings and Breast Cancer Drug Sales
Source: Streetwise Reports  (8/9/19)
Shares in Puma Biotechnology are trading 20% higher today after the company released Q2/19 earnings and reported positive NERLYNX revenue growth. More >

Avedro Shares Looking Up 35% with Glaukos Merger
Source: Streetwise Reports  (8/8/19)
Avedro Inc. and Glaukos Corp. announced that the firms' boards of directors have executed a definitive merger agreement. The all-stock deal is expected to close in Q4/19. More >

Guardant Health Reports Quarterly Revenue Up 178%
Source: Streetwise Reports  (8/7/19)
Guardant Health Inc. reported strong growth for Q2/19 versus the same period last year and raised its full-year 2019 revenue guidance to $180–190 million. More >

Allakos Shares Double on AK002 Phase 2 Results and Earnings
Source: Streetwise Reports  (8/5/19)
Allakos Inc. shares are soaring today as the company reported Q2/19 earnings and announced positive results from its phase 2 study for its AK002 inhibitor used in the treatment of eosinophil and mast cell related diseases. More >

Biotech 'Thinking Several Steps Ahead with Optimizing IVR Quality Control'
Source: Streetwise Reports  (8/2/19)
The company's latest science, presented at a recent conference, is discussed in a ROTH Capital Partners report. More >

Biotech's Mosquito Test 'Gains Market Acceptance'
Source: Streetwise Reports  (8/2/19)
This West Nile virus test and others including cancer diagnostic tests in the Utah company's pipeline are discussed in an H.C. Wainwright & Co. report. More >

Tandem Increases Unit Sales of t:slim X2 Insulin Pumps 290% Worldwide
Source: Streetwise Reports  (8/2/19)
Tandem Diabetes Care's second quarter earnings highlighted a 290% increase in unit sales of its t:slim X2 insulin pumps that feature integrated continuous glucose monitoring and remote software update capability. More >

Gaia Grow Corp. Plants 1,494 Acres of Hemp in Canada and Plans First Harvest in 2 Months
Source: Peter Epstein for Streetwise Reports  (8/1/19)
Gaia Grow Corp. CEO Frederick Pels speaks with Peter Epstein of Epstein Research on the day his company begins trading on the TSX Venture Exchange. More >

Led by Sales of HETLIOZ, Vanda Increases Quarterly Revenues by 25%
Source: Streetwise Reports  (8/1/19)
Shares of Vanda Pharmaceuticals traded nearly 30% higher after the company released Q2/19 earnings and positive sales trends for both HETLIOZ and Fanapt. More >

EMA Opinion Bodes Well for Biopharma's Drug Getting Orphan Status
Source: Streetwise Reports  (7/31/19)
The designation, opinion and asset are discussed in a ROTH Capital Partners report. More >